1. Home
  2. RCUS vs HCSG Comparison

RCUS vs HCSG Comparison

Compare RCUS & HCSG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCUS
  • HCSG
  • Stock Information
  • Founded
  • RCUS 2015
  • HCSG 1976
  • Country
  • RCUS United States
  • HCSG United States
  • Employees
  • RCUS N/A
  • HCSG N/A
  • Industry
  • RCUS Biotechnology: Pharmaceutical Preparations
  • HCSG Assisted Living Services
  • Sector
  • RCUS Health Care
  • HCSG Health Care
  • Exchange
  • RCUS Nasdaq
  • HCSG Nasdaq
  • Market Cap
  • RCUS 727.1M
  • HCSG 838.4M
  • IPO Year
  • RCUS 2018
  • HCSG N/A
  • Fundamental
  • Price
  • RCUS $7.88
  • HCSG $9.52
  • Analyst Decision
  • RCUS Strong Buy
  • HCSG Buy
  • Analyst Count
  • RCUS 10
  • HCSG 4
  • Target Price
  • RCUS $29.50
  • HCSG $14.00
  • AVG Volume (30 Days)
  • RCUS 1.2M
  • HCSG 488.2K
  • Earning Date
  • RCUS 05-07-2025
  • HCSG 04-23-2025
  • Dividend Yield
  • RCUS N/A
  • HCSG N/A
  • EPS Growth
  • RCUS N/A
  • HCSG 2.57
  • EPS
  • RCUS N/A
  • HCSG 0.53
  • Revenue
  • RCUS $258,000,000.00
  • HCSG $1,715,682,000.00
  • Revenue This Year
  • RCUS N/A
  • HCSG $6.60
  • Revenue Next Year
  • RCUS $25.77
  • HCSG $4.05
  • P/E Ratio
  • RCUS N/A
  • HCSG $17.96
  • Revenue Growth
  • RCUS 120.51
  • HCSG 2.65
  • 52 Week Low
  • RCUS $6.50
  • HCSG $9.50
  • 52 Week High
  • RCUS $18.98
  • HCSG $12.99
  • Technical
  • Relative Strength Index (RSI)
  • RCUS 44.26
  • HCSG 34.23
  • Support Level
  • RCUS $6.75
  • HCSG $9.52
  • Resistance Level
  • RCUS $8.36
  • HCSG $10.33
  • Average True Range (ATR)
  • RCUS 0.60
  • HCSG 0.35
  • MACD
  • RCUS 0.16
  • HCSG -0.04
  • Stochastic Oscillator
  • RCUS 74.19
  • HCSG 11.96

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

About HCSG Healthcare Services Group Inc.

Healthcare Services Group Inc is a provider of housekeeping and facility management services to the healthcare industry. The company operates two business segments, both contributing roughly equally to the company's revenue: Housekeeping, laundry, linen, and other services; and Dietary department services. Housekeeping includes management of clients' housekeeping departments, cleaning, disinfecting and sanitizing, laundry, bed linen, and uniform services. Dietary consists of food purchasing, meal preparation, and providing dietitian consulting services. Its clients are nursing homes, retirement complexes, rehabilitation centers, and hospitals in the United States of America.

Share on Social Networks: